Read Time:2 Minute, 54 Second ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs April 29, 2021 Share English Health Press Release ISSAR Pharma, the only company in India which focuses on the research and development of New Chemical Entities (NCE), is licensing out its NCEs based...